Basit öğe kaydını göster

dc.contributor.authorAcarli, K
dc.contributor.authorTekant, Y
dc.contributor.authorRozanes, I
dc.contributor.authorAriogul, O
dc.contributor.authorAcunas, B
dc.contributor.authorEmre, A
dc.contributor.authorOzden, I
dc.contributor.authorBilge, O
dc.contributor.authorArici, C
dc.contributor.authorAlper, A
dc.contributor.authorOkten, A
dc.date.accessioned2021-03-03T07:42:35Z
dc.date.available2021-03-03T07:42:35Z
dc.date.issued2003
dc.identifier.citationEmre A., Ozden I., Bilge O., Arici C., Alper A., Okten A., Acunas B., Rozanes I., Acarli K., Tekant Y., et al., "Alveolar echinococcosis in Turkey - Experience from an endemic region", DIGESTIVE SURGERY, cilt.20, sa.4, ss.301-305, 2003
dc.identifier.issn0253-4886
dc.identifier.othervv_1032021
dc.identifier.otherav_136b0245-f1d2-4eed-a999-8958881668be
dc.identifier.urihttp://hdl.handle.net/20.500.12627/18506
dc.identifier.urihttps://doi.org/10.1159/000071695
dc.description.abstractBackground: Radical resection is the only potentially curative treatment for hepatic alveolar echinococcosis (AE). Although Turkey is an endemic region, population screening is not performed and early diagnosis is rare. Consequently, surgeons are compelled to explore possibilities such as near-total resection and biliodigestive anastomosis for palliation of jaundice. Methods: Surgery was performed in 32 patients with hepatic AE with the following indications: (1) resection; (2) palliation of jaundice; (3) definite assessment of operability; (4) failure in the management of cavity infection by percutaneous methods. Curative resection (R0 = complete resection of all parasitic mass [n = 9], and R1 = a resection in which a small remnant was left on a vital structure [n = 81) were performed in 17 patients, intrahepatic cholangiojejunostomy in 7, laparotomy-external drainage in 7, and debulking in 1. Results: Perioperative mortality rates were 2/17, 0/7, 2/7 and 1/1, respectively. Twelve patients in the curative resection group are alive without recurrence/ progression of the small remnant during a median follow-up of 59 (range 27-116) months. One patient developed an inoperable recurrence that was treated with albendazole. One patient was lost to follow-up. Longterm albendazole treatment was effective in all R1 patients except a patient who had slow asymptomatic progression. Successful palliation of jaundice was achieved in 5 of the 7 intrahepatic cholangiojejunostomy patients. Conclusions:The results of R1 resection in alveolar hydatid disease are similar to those of R0 resection; a small remnant is successfully controlled by albendazole. In patients with jaundice due to hilar invasion, biliary diversion from segment 3 or 5 is effective for palliation of the jaundice and facilitates albendazole treatment. Copyright (C) 2003 S. Karger AG, Basel.
dc.language.isoeng
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectCerrahi Tıp Bilimleri
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleAlveolar echinococcosis in Turkey - Experience from an endemic region
dc.typeMakale
dc.relation.journalDIGESTIVE SURGERY
dc.contributor.department, ,
dc.identifier.volume20
dc.identifier.issue4
dc.identifier.startpage301
dc.identifier.endpage305
dc.contributor.firstauthorID16096


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster